South Korea's Pharma-Bio Firms to Invest $95 Million in COVID-19 Projects, an Industrial Info Market Brief
South Korea's Pharma-Bio Firms to Invest $95 Million in COVID-19 Projects, an Industrial Info Market Brief
Attachment: SK COVID phamra 0920
Industrial Info is tracking 10 active projects related to COVID-19 equipement and treatments across South Korea, with a total investment of nearly $95 million. Seven projects, worth more than $62 million, are related to KF94 mask production.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
